AGUIARI, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 5.251
EU - Europa 3.015
AS - Asia 1.561
SA - Sud America 294
AF - Africa 37
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.165
Nazione #
US - Stati Uniti d'America 5.191
DE - Germania 1.189
SG - Singapore 628
IT - Italia 612
CN - Cina 540
RU - Federazione Russa 313
BR - Brasile 272
UA - Ucraina 260
GB - Regno Unito 172
TR - Turchia 162
FI - Finlandia 149
SE - Svezia 78
PL - Polonia 68
HK - Hong Kong 64
ID - Indonesia 41
BE - Belgio 39
CA - Canada 37
FR - Francia 33
IN - India 32
NL - Olanda 27
CZ - Repubblica Ceca 19
ZA - Sudafrica 16
AT - Austria 15
BD - Bangladesh 14
VN - Vietnam 14
MX - Messico 11
PK - Pakistan 11
ES - Italia 10
LT - Lituania 10
AR - Argentina 8
IQ - Iraq 8
JP - Giappone 8
CH - Svizzera 7
KR - Corea 6
MA - Marocco 6
UZ - Uzbekistan 6
IR - Iran 5
JM - Giamaica 5
NG - Nigeria 5
DK - Danimarca 4
EC - Ecuador 4
RO - Romania 4
TH - Thailandia 4
CO - Colombia 3
CR - Costa Rica 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BH - Bahrain 1
CL - Cile 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
UY - Uruguay 1
Totale 10.165
Città #
Woodbridge 576
Fairfield 507
Ashburn 456
Chandler 374
Ann Arbor 346
Santa Clara 305
Houston 301
Singapore 294
Jacksonville 291
Seattle 221
Wilmington 215
Cambridge 176
Munich 173
Beijing 145
Ferrara 143
Izmir 95
Nanjing 77
Princeton 76
Warsaw 67
New York 65
Shanghai 62
Hong Kong 59
Turku 59
San Diego 58
Milan 56
Los Angeles 47
Boardman 42
Parma 39
Jakarta 36
Brussels 35
Bologna 34
Tianjin 30
Helsinki 29
Shenyang 29
London 27
Nanchang 26
Bremen 25
Rome 21
Trevignano 21
Hebei 18
San Mateo 18
Addison 17
São Paulo 17
Falkenstein 16
Falls Church 15
Moscow 15
Nuremberg 15
Chicago 14
Nervesa della Battaglia 14
Redwood City 14
San Francisco 14
Cassago Brianza 13
Dearborn 13
Hefei 13
Ottawa 13
Brno 12
Changsha 12
Jinan 12
Kunming 12
Macherio 12
Norwalk 12
Guangzhou 11
Jiaxing 11
Quinto di Treviso 11
Stockholm 11
Verona 11
Auburn Hills 10
Belo Horizonte 10
Brooklyn 10
Frankfurt am Main 10
Montebelluna 10
Toronto 10
Ningbo 9
Philadelphia 9
Washington 9
Zhengzhou 9
Atlanta 8
Mountain View 8
Padova 8
Augusta 7
Boston 7
Dallas 7
Modena 7
Ponzano Veneto 7
Tokyo 7
Vienna 7
Amsterdam 6
Brasília 6
Columbus 6
Montreal 6
Olomouc 6
Phoenix 6
Rio de Janeiro 6
San Vittore Olona 6
Secaucus 6
Ankara 5
Dhaka 5
Ferrara di Monte Baldo 5
Florence 5
Hanoi 5
Totale 6.252
Nome #
Berberine slows cell growth in autosomal dominant polycystic kidney disease cells. 206
Analysis of published PKD1 gene sequence variants 205
The activation of mTOR independent autophagy in kidney carcinoma cells by the upregulation of miR501-5p occurs through the decrease of mitochondrial calcium uptake 202
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia. 179
Autosomal dominant polycystic kidney disease linked to PKD2 locus in a family with severe extrarenal manifestations 175
Role of calcium in polycystic kidney disease: From signaling to pathology 175
Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene 171
Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation 169
Cis element "decoy"against the upstream promoter of the human estrogen receptor gene 165
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 163
MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells 162
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 160
Drug repurposing and transposable elements: a new promising strategy to fight prostate cancer 158
INHIBITION OF AUTOPHAGY INCREASES THE RESPONSE TO SUNITINIB IN CCRCC CELL LINES 156
Effects of a Hydroxyapatite-based Biomaterial on Gene Expression in Osteoblast-like Cells. 155
Il Registro Italiano del Rene Policistico Autosomico Dominante 154
In vitro stability of polymerase chain reaction-generated DNA fragments in serum and cell extracts 153
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 153
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells. 152
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 152
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 149
Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions 148
MIR-501 DEPLETION INDUCES CELL CYCLE INHIBITION BY MTOR AND P53 MODULATION IN RENAL CARCINOMA 147
Somatic and germline variants affect prognosis and susceptibility in prostate cancer 146
Mutations in autosomal dominant polycystic kidney disease 2 gene: Reduced expression of PKD2 protein in lymphoblastoid cells. 145
Nonspecific cation current associated with native polycystin-2 in HEK-293 cells 144
miR-501 overexpression in renal carcinomas 143
Multidrug therapy for polycystic kidney disease: a review and perspective 139
null 138
The induction of AMPK-dependent autophagy leads to P53 degradation and affects cell growth and migration in kidney cancer cells 138
Sequencing of an RNA transcript of the human estrogen receptor gene: evidence for a new transcriptional event. 134
Novel splicing and missense mutations in autosomal dominant polycystic kidney disease 1 (PKD1) gene: expression of mutated genes. 133
Loss of heterozygosity in ovarian cancer: detection by PCR and microsatellite polymorphism. 133
LOH of Chromosome 6q compared with LOH of 17q and 18q in ovarian cancers: relationship to p53 expression and clinicopahological findings 132
MiR501-5p stimulating the activity of mToR may result a risk factor for a poor prognosis of clear cell kidney carcinoma 132
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 129
Androgen responsiveness and androgen receptor gene expression in human kidney cells in continuous culture. 127
null 126
Modulation of estrogen receptor gene expression in human breast cancer cells: a decoy strategy with specific PCR-generated DNA fragments. 124
K562 erytrhoid and HL60 macrophage differentiation down regulates polycystin, a large membrane associated protein 121
Detection of androgen receptor (AR) mRNA by the reverse transcription polymerase chain reaction (RT-PCR) in human thyroids. 119
Inhibitory effect of dihydrotestosterone on human thyroid cell growth 118
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 118
MicroRNA501-5p activating the mTOR independent autophagy induces p53 degradation in kidney cancer cells 116
null 113
Calcium homeostasis and polycystin expression in t-lynphoblasts of ADPKD patients 113
null 111
TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes 110
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 109
A native voltage-dependent non selective cation current in HEK-293 cells 108
null 107
Direct transfection of PCR- generated DNA fragments into mammalian cells employing ethidium bromide indicator and ultrafiltration 106
Increased of A3 adenosine receptors by depleted expression of polycystic kidney disease-1 gene (PKD1) in human renal cell and tissues: implication for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells 105
null 103
null 102
null 99
Autophagy suppression potentiates the sunitinib-dependent inhibition of cell growth and migration in kidney carcinoma cells 99
Regulatory RNAs of the Transglutaminase 2 gene interfere with its expression in leukaemic cell lines after ATRA treatment 97
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 97
THE INHIBITION OF AUTOPHAGY INCREASES SUNITINIB RESPONSE IN KIDNEY CANCER CELLS 94
Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor alpha gene 94
Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer 94
Polycystin-1 promotes PKC alpha-mediated NF-kappa B activation in kidney cells 94
null 94
Inhibition of autophagy reduces cell proliferation and migration by P53 restoring in ccRCC cells 93
Suppression of pkhd1 impairs survival in cultured kidney tubular cells. 88
Role of the miR-501 in Renal Carcinomas 87
Targeted Sequencing Approach For Prostate Cancer Using Ion Torrent Personal Genome Machine (PGM ™) Platform 82
null 79
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells 77
Detection of disease-causing mutations in prostate cancer by NGS sequencing 73
MICRORNA501 UP-REGULATION MAY INCREASE THE AGGRESSIVENESS OF CLEAR CELL RENAL CARCINOMA THROUGH MTOR ACTIVATION AND P53 DEGRADATION 68
MicroRNA501 may affect the aggressiveness of clear cell renal carcinoma 65
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy 65
A COMBINATION OF TYROSINE KINASE AND AUTOPHAGY INHIBITORS STRENGHTHENS THE INHIBITION OF ANGIOGENIC PATHWAY IN KIDNEY CARCINOMA CELL LINES 64
null 64
Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance 57
Differential expression of microRNA501-5p affects the aggressiveness of clear cell renal carcinoma 56
NF-kB activation is required for apoptosis in fibrocystin7polyductin-depleted kidney epithelial cells 54
The mystery of mitochondria-ER contact sites in physiology and pathology: A cancer perspective 53
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 51
Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. 48
The cytoplasmic C-terminus of polycystin-1 increases cell proliferation in kidney epithelial cells through serum-activated and Ca2+-dependent pathway(s) 46
THE AUTOPHAGY INHIBITOR DESMETHYLCLOMIPRAMINE REDUCES EPITHELIAL–MESENCHYMAL TRANSITION, PROLIFERATION, AND INVASION IN KIDNEY CARCINOMA CELL LINES 45
Transglutaminase-2 inhibition restores P53 expression preventing its degradation by autophagic pathway in ccRCC cells 45
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2 40
Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy 40
Expression of polycystin-1 C-terminal fragment enhances the ATP-induced Ca2+ release in human kidney cells 37
New Therapeutic Interventions for Kidney Carcinoma: Looking to the Future. 36
The inhibition of MDM2 slows cell proliferation and activates apoptosis in ADPKD cell lines 35
State-of-the-art in transposable element modulation affected by drugs in malignant prostatic cancer cells 34
MICRORNA501-5P INCREASES AUTOPHAGY IN CLEAR CELL RENAL CELL CARCINOMA 34
MicroRNAs in clear cell renal cell carcinoma: biological functions and applications 33
The Role of Genetic Polymorphisms in the Diagnosis and Management of Prostate Cancer: An Update 24
Expression of protein fragments from the human PKD1 gene and production of rabbit polyclonal antibodies to the recombinant proteins. 22
Totale 10.308
Categoria #
all - tutte 47.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.078 148 69 110 137 56 82 44 105 29 102 135 61
2021/2022755 24 86 53 37 48 21 40 48 24 62 73 239
2022/2023896 91 66 33 120 119 138 45 73 115 11 48 37
2023/2024656 41 51 24 23 76 101 40 25 9 18 18 230
2024/20252.413 91 127 204 154 253 219 69 116 326 239 353 262
2025/2026426 426 0 0 0 0 0 0 0 0 0 0 0
Totale 10.308